+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of third-generation cephalosporins restriction on the control of an extended-spectrum beta-lactamases producing Klebsiella pneumoniae outbreak in ICU



Impact of third-generation cephalosporins restriction on the control of an extended-spectrum beta-lactamases producing Klebsiella pneumoniae outbreak in ICU



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 222




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031832835

Download citation: RISBibTeXText


Related references

Transfer of resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases. Epidemiologie Mikrobiologie Imunologie 48(1): 21-27, 1999

Transferable resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing beta-lactamases with an extended spectrum (ESBL). Epidemiologie Mikrobiologie Imunologie 48(1): 21-27, 1999

Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrobial Agents and ChemoTherapy 42(1): 53-58, 1998

First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum beta-lactamases in Korea. Antimicrobial Agents and ChemoTherapy 49(11): 4809-4810, 2005

An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: The importance of using cefpodoxime to detect extended-spectrum beta-lactamases. Journal of Antimicrobial Chemotherapy 51(1): 195-196, 2003

Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extended-spectrum beta-lactamases. Journal of Hospital Infection 72(1): 23-29, 2009

Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infection Control and Hospital Epidemiology 25(10): 832-837, 2004

Phenotypic profiling of third-generation cephalosporins Impact on screening for putative extended-spectrum beta-lactamases in E coli and K pneumoniae. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 155, 2001

Extended Spectrum Beta-Lactamase-producing Klebsiella pneumoniae outbreaks during a third generation cephalosporin restriction policy. Journal of ChemoTherapy 17(1): 66-73, 2005

Incidence of extended-spectrum beta-lactamases and characterization of integrons in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Shantou, China. Acta Biochimica et Biophysica Sinica 39(7): 527-532, 2007

Characterization of Klebsiella pneumoniae strains producing extended spectrum beta-lactamases and AMPC type beta-lactamases isolated from hospitalized patients in Kerman, Iran. Roumanian Archives of Microbiology and Immunology 71(2): 81-86, 2012

Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases. Diagnostic Microbiology and Infectious Disease 61(3): 343-345, 2008

Impact of a clonal outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K pneumoniae and Escherichia coli an 11 year experience in Oxfordshire, UK. 2011

Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?. Journal of Global Antimicrobial Resistance 19: 28-31, 2019

Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting. Journal of ChemoTherapy 30(3): 150-156, 2018